Cree, Inc. [NASDAQ:CREE]: Analyst Rating and Earnings
Equities traders frequently stay up to date regarding what leading market analysts think about a possible stock buy. As it relates to Cree, Inc. [CREE], the latest mean analyst recommendation that’s publicly available is from the fiscal three-month period ending in June. On average, stock market experts give CREE an Outperform rating. The average 12-month price forecast for this stock is $47.91, with the high estimate being $60.00, the low estimate being $35.00 and the median estimate amounting to $46.00. This is compared to its latest closing price of $44.38.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Cree, Inc. [CREE] is sitting at 2.20. This is compared to 1 month ago, when its average rating was 2.20.
For the quarter ending in Sep-18 Cree, Inc. [CREE] generated $0.41 billion in sales. That’s 0.23% higher than the average estimate of $0.41 billion as provided by Wall Street analysts. The three indicators above suggest that overall, this stock is demonstrating a mixed bag of positive appeal and some drawbacks, making it a somewhat risky investment that also has the potential to generate high ROI in the long run.
Stay on the lookout for the next quarterly financial report – the company is expected to release the following results on Wed 30 Jan (In 20 Days).
Fundamental Analysis of Cree, Inc. [CREE]
Now let’s turn to look at profitability: with a current Operating Margin for Cree, Inc. [CREE] sitting at -4.37 and its Gross Margin at +25.23, this company’s Net Margin is now -17.60%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.
This company’s Return on Total Capital is -2.76, and its Return on Invested Capital has reached -13.40%. Its Return on Equity is -13.05, and its Return on Assets is -10.59. These metrics suggest that this Cree, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.
Turning to investigate this organization’s capital structure, Cree, Inc. [CREE] has generated a Total Debt to Total Equity ratio of 14.13. Similarly, its Total Debt to Total Capital is 12.38, while its Total Debt to Total Assets stands at 11.07. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 14.13, and its Long-Term Debt to Total Capital is 12.38. This company is not leveraging its assets to take on debt, which stunts its growth and limits the ROI for investors.
What about valuation? This company’s Enterprise Value to EBITDA is 46.47 and its Total Debt to EBITDA Value is 3.29. The Enterprise Value to Sales for this firm is now 2.67, and its Total Debt to Enterprise Value stands at 0.06. Cree, Inc. [CREE] has a Price to Book Ratio of 2.34, a Price to Cash Flow Ratio of 28.34.
Shifting the focus to workforce efficiency, Cree, Inc. [CREE] earns $219,788 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 9.55 and its Total Asset Turnover is 0.56. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 2.39 and its Current Ratio is 3.58. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Let’s now turn our attention to trading performance: Cree, Inc. [CREE] has 104.83M shares outstanding, amounting to a total market cap of $4.76B. Its stock price has been found in the range of 30.78 to 51.78. At its current price, it has moved by -12.22% from its 52-week high, and it has moved 47.66% from its 52-week low.
This stock’s Beta value is currently 0.45, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 59.69. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Cree, Inc. [CREE] a Reliable Buy?
Shares of Cree, Inc. [CREE], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.